Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model
- 30 April 2000
- journal article
- Published by Elsevier in Clinical Nutrition
- Vol. 19 (2) , 127-132
- https://doi.org/10.1054/clnu.1999.0090
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Insulin Resistance in Cancer Patients Is Associated with Enhanced Tumor Necrosis Factor-α Expression in Skeletal MuscleBiochemical and Biophysical Research Communications, 1998
- Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin‐like growth factor systemClinical Endocrinology, 1996
- Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized ratsBone, 1995
- Growth Hormone and Prostate Cancer Growth and Metastasis in Tumor-Bearing AnimalsJournal of Pediatric Endocrinology and Metabolism, 1993
- The metabolic response to cancerProceedings of the Nutrition Society, 1992
- Measurement of hepatic protein synthesis in unrestrained mice-evaluation of the ‘flooding technique’Acta Physiologica Scandinavica, 1991
- Insulin resistance in patients with colorectal cancerBritish Journal of Surgery, 1987
- Protein and Energy Metabolism with Biosynthetic Human Growth Hormone after Gastrointestinal SurgeryAnnals of Surgery, 1987
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980
- A comparative study of the influence of malignant tumor on host metabolism in mice and man.Evaluation of an experimental modelCancer, 1978